Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.
Danielle HammondSanam LoghaviSa A WangMarina Y KonoplevaTapan Mahendra KadiaNaval G DaverMaro OhanianGhayas C IssaYesid AlvaradoNicholas James ShortKoji SasakiNaveen PemmarajuGuillermo Montalban-BravoCurtis A LachowiezAbhishek MaitiGuillermo Garcia ManeroElias J JabbourGautam BorthakurFarhad RavandiKoichi TakahashiSherry R PierceHagop M KantarjianCourtney D D DiNardoPublished in: Blood cancer journal (2023)